4.6 Article

Towards Next Generation Adenosine A2A Receptor Antagonists

期刊

CURRENT MEDICINAL CHEMISTRY
卷 21, 期 34, 页码 3918-3935

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666140826115123

关键词

A(2A)R antagonists; aqueous solubility; cancer immunotherapy; molecular modeling; parkinson's disease; PET imaging; X-ray crystallography

向作者/读者索取更多资源

The Adenosine A2A receptor is a member of the G-protein coupled receptor superfamily. It plays a key role in numerous physiological processes through the central nervous system and in peripheral tissues. Functional interactions between the A2A and dopamine D2 receptor has spurred interest in the use of antagonists as anti-Parkinson drugs. Additionally, oncology drugs are now being designed based on the potential for A2A antagonists to function as immunotherapeutics. From early studies based on classical xanthine type A2A antagonists through second generation agents, this mini review will cover aspects of the discovery, development, chemical synthesis and medicinal evaluation of this important class of drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据